Clinical Trials Directory

Trials / Completed

CompletedNCT04030832

Reconstruction of Skin Substance Loss With "Micro-grafts" Obtained by Mechanical Disintegration

Reconstruction of Skin Substance Loss With Method of "Micro-grafts" Obtained by Mechanical Disintegration: Preliminary Study

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Azienda Ospedaliero, Universitaria Ospedali Riuniti · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The etiology of non-healing ulcers depends on both systemic and local factors. The introduction of advanced dressing, negative wound therapy and compression therapy have undoubtedly improved clinical outcomes. The principal aim of study was to demonstrate the efficacy of skin micrografts in the treatment of skin substance loss.

Detailed description

The principal aim of study was to evaluate the efficacy of skin micro-grafts obtained with the system of mechanical disintegration in the reconstruction of skin substance loss in the limbs. The primary endpoint consists in evaluating, through a specific evaluation scale, the Wound Bed Score (WBS) for skin substance loss at Time 0 (T0) and 30 days after the procedure (T30) and to evaluate the increase of this score in this time frame set at 50%. The evaluation will be carried out in double blind. The secondary endpoints instead consist in the evaluation of the Wound Surface Area Assessment to be carried out at T0 and T30. In the evaluation of the quality of the resulting scars, through the Vancouver Scale (VS), 90 (T90) and 180 days (T180) after treatment and to evaluate the reduction of this score by 15%; on the other in the evaluation of the progress of the Visual Analogic Scale (VAS) administered to the patient at T0, 30, 90, 180. The purpose of this minimally invasive treatment is to improve the quality of life of those affected by these injuries, avoiding the use of prolonged advanced medications and / or more invasive surgical procedures, thus speeding up healing and favoring the clinical outcome of patients. No chemical reagents or enzymes are used for the method. There is therefore no tissue manipulation, in full compliance with the European directive 23/2004.

Conditions

Timeline

Start date
2017-10-01
Primary completion
2018-10-01
Completion
2019-06-30
First posted
2019-07-24
Last updated
2019-07-24

Locations

4 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT04030832. Inclusion in this directory is not an endorsement.

Reconstruction of Skin Substance Loss With "Micro-grafts" Obtained by Mechanical Disintegration (NCT04030832) · Clinical Trials Directory